TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant
Phase 4
200
about 6.7 years
18+
1 site in CA
What this study is about
Researchers are testing whether a continuous infusion of ropivacaine through catheters, or a single dose of liposomal bupivacaine, provides better pain relief after kidney transplantation. The trial will involve adults who have undergone kidney transplants and are experiencing postoperative pain.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Ropivacaine Continuous Infusion Catheter
- 2.Take Single Dose Liposomal Bupivicaine
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
NERVOUS SYSTEM, local anesthetic
infusion
Secondary: Post Operative Care Unit and Hospital Length of Stay, Proportion of pain scores indicating severe pain
therapeutic
Renal